• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性视神经病变

Ischemic optic neuropathies.

作者信息

Luneau Katie, Newman Nancy J, Biousse Valérie

机构信息

Departments of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

出版信息

Neurologist. 2008 Nov;14(6):341-54. doi: 10.1097/NRL.0b013e318177394b.

DOI:10.1097/NRL.0b013e318177394b
PMID:19008740
Abstract

Anterior ischemic optic neuropathy (AION) is the most common cause of acute optic neuropathy after age 50, but may also occur in younger patients. The diagnosis is clinical and includes painless visual loss associated with a relative afferent pupillary defect and disc edema. In almost all cases, there is an underlying crowded optic nerve with a small cup-to-disc ratio. The visual prognosis is usually poor, although up to 43% of patients may improve over time. The fellow eye is involved in up to 15% of patients within 5 years, but the risk of recurrence in the same eye is less than 5%. There is no treatment for acute nonarteritic AION but it is essential to evaluate these patients for underlying treatable atheromatous vascular risk factors. A coagulation workup should also be considered in younger patients. It is essential to rule out giant cell arteritis in all patients over the age of 50 with ischemic optic neuropathies. Posterior ischemic neuropathy (in which the optic nerve is normal acutely) is rare and should be considered a diagnosis of exclusion.

摘要

前部缺血性视神经病变(AION)是50岁以后急性视神经病变最常见的病因,但也可能发生于较年轻的患者。诊断依靠临床症状,包括与相对传入性瞳孔障碍及视盘水肿相关的无痛性视力丧失。几乎在所有病例中,都存在潜在的视神经拥挤,杯盘比小。视力预后通常较差,不过高达43%的患者视力可能随时间改善。在5年内,对侧眼累及率高达15%,但同一只眼复发风险低于5%。急性非动脉炎性AION尚无治疗方法,但评估这些患者潜在的可治疗动脉粥样硬化血管危险因素至关重要。对于较年轻的患者,也应考虑进行凝血检查。对于所有50岁以上患有缺血性视神经病变的患者,排除巨细胞动脉炎至关重要。后部缺血性神经病变(急性时视神经正常)罕见,应作为排除性诊断。

相似文献

1
Ischemic optic neuropathies.缺血性视神经病变
Neurologist. 2008 Nov;14(6):341-54. doi: 10.1097/NRL.0b013e318177394b.
2
[Ischemic optic neuropathy. Pathogenesis, clinical features, diagnostics and treatment].[缺血性视神经病变。发病机制、临床特征、诊断与治疗]
Klin Oczna. 2006;108(4-6):238-42.
3
Ischemic optic neuropathy.缺血性视神经病变
Semin Neurol. 2007 Jul;27(3):221-32. doi: 10.1055/s-2007-979686.
4
Optic disc structure and shock-induced anterior ischemic optic neuropathy.视盘结构与冲击性前部缺血性视神经病变
Ophthalmology. 2003 Feb;110(2):327-31. doi: 10.1016/S0161-6420(02)01736-0.
5
Bilateral ischemic optic neuropathy after transurethral prostatic resection: a case report.经尿道前列腺切除术后双侧缺血性视神经病变:一例报告
BMC Ophthalmol. 2006 Oct 11;6:32. doi: 10.1186/1471-2415-6-32.
6
Anterior ischemic optic neuropathy in patients younger than 50 years.50岁以下患者的前部缺血性视神经病变
Am J Ophthalmol. 2007 Dec;144(6):953-60. doi: 10.1016/j.ajo.2007.07.031. Epub 2007 Sep 14.
7
[Optic nerve neuropathy in the course of giant cell arteritis].[巨细胞动脉炎病程中的视神经病变]
Klin Oczna. 2003;105(3-4):217-20.
8
[Risk factors and clinical fluorescein angiography findings in anterior ischemic optic neuropathy].前部缺血性视神经病变的危险因素及临床荧光素血管造影表现
Ophthalmologe. 1996 Aug;93(4):354-60.
9
Non-arteritic anterior ischaemic optic neuropathy: a review and update.非动脉炎性前部缺血性视神经病变:综述与更新
J Clin Neurosci. 2009 Aug;16(8):994-1000. doi: 10.1016/j.jocn.2009.04.002.
10
Development of bilateral, nonarteritic anterior ischemic optic neuropathy in an eye with diabetic papillopathy.糖尿病性视乳头病变患者单侧眼发生双侧非动脉炎性前部缺血性视神经病变
Jpn J Ophthalmol. 2004 Mar-Apr;48(2):158-62. doi: 10.1007/s10384-003-0034-y.

引用本文的文献

1
Amiodarone-related keratopathy and optic neuropathy: case report and literature review.胺碘酮相关性角膜病变和视神经病变:病例报告及文献综述
Front Med (Lausanne). 2025 Apr 2;12:1572461. doi: 10.3389/fmed.2025.1572461. eCollection 2025.
2
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review.嗜酸粒细胞相关疾病的眼部血管表现:CEREO 和 EESG 网络中 57 例患者的综合分析及文献复习。
Front Immunol. 2024 Apr 23;15:1379611. doi: 10.3389/fimmu.2024.1379611. eCollection 2024.
3
Efficacy and safety of platelet-rich plasma for acute nonarteritic anterior ischemic optic neuropathy: a prospective cohort study.
富血小板血浆治疗急性非动脉炎性前部缺血性视神经病变的疗效和安全性:一项前瞻性队列研究。
Front Med (Lausanne). 2024 Mar 13;11:1344107. doi: 10.3389/fmed.2024.1344107. eCollection 2024.
4
The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy.舒马曲坦引发的非动脉炎性前部缺血性视神经病变的病理生理学。
Rom J Ophthalmol. 2022 Oct-Dec;66(4):352-355. doi: 10.22336/rjo.2022.62.
5
Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases.梓醇:一种用于预防和治疗慢性疾病的有前景的类黄酮。
Biomolecules. 2022 Aug 26;12(9):1185. doi: 10.3390/biom12091185.
6
Incidence and risk factors of postoperative visual function impairment in elderly patients undergoing nonocular surgery: a prospective cohort study.老年非眼部手术患者术后视觉功能障碍的发生率及危险因素:一项前瞻性队列研究。
Braz J Anesthesiol. 2021 Nov-Dec;71(6):599-606. doi: 10.1016/j.bjane.2021.09.002. Epub 2021 Oct 1.
7
Imageology of internal carotid artery siphon in non-arteritic anterior ischaemic optic neuropathy.非动脉炎性前部缺血性视神经病变的颈内动脉虹吸部影像学表现
Int J Ophthalmol. 2020 Dec 18;13(12):1941-1947. doi: 10.18240/ijo.2020.12.15. eCollection 2020.
8
Evaluation of enhanced external counterpulsation therapy for nonarteritic anterior ischemic optic neuropathy.增强型体外反搏治疗非动脉炎性前部缺血性视神经病变的评估。
BMC Ophthalmol. 2020 Jun 17;20(1):236. doi: 10.1186/s12886-020-01509-7.
9
Quantitative analysis of optical coherence tomographic angiography (OCT-A) in patients with non-arteritic anterior ischemic optic neuropathy (NAION) corresponds to visual function.非动脉炎性前部缺血性视神经病变(NAION)患者的光学相干断层扫描血管造影(OCT-A)定量分析与视觉功能相对应。
PLoS One. 2018 Jun 28;13(6):e0199793. doi: 10.1371/journal.pone.0199793. eCollection 2018.
10
The risk of ischemic optic neuropathy post phacoemulsification cataract surgery.白内障超声乳化吸除术后缺血性视神经病变的风险。
Pan Afr Med J. 2017 Sep 21;28:53. doi: 10.11604/pamj.2017.28.53.10806. eCollection 2017.